North America electronic clinical outcome assessment (eCOA) market is projected to register a healthy CAGR in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
North America Electronic Clinical Outcome Assessment (eCOA) Market By Product (On-Premise Solutions, Cloud Based Solutions and Web Based Solutions), Approach (Clinician Reported Outcome Assessment (CLINRO), Patient Reported Outcome Assessment (PRO), Observer Reported Outcome Assessment (OBSRO) and Performance Outcome Assessment (PERFO)), End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Laboratories and Academic Institutions), Platform (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Hospitals and Clinical Laboratories, Consulting Service Companies, Research and Academia and Others), Country (U.S., Canada, Mexico), Market Trends and Forecast to 2027.
Some of the major factors contributing to the growth of the North America electronic clinical outcome assessment (eCOA) market are:

• High rate of adoption of technology by end users
• Large number of solution vendors headquartered and operational in the region

Market Players:

The key market players for North America electronic clinical outcome assessment (eCOA) market are listed below:

• Oracle
• Parexel International Corporation
• ERT Clinical
• Bioclinica
• IBM Corporation
• eClinical Solutions LLC
• ArisGlobal LLC
• Signant Health
• Medidata
• Omnicomm Systems, Inc.
• YPrime, LLC
• Clinical Ink
• WIRB-Copernicus Group